Becton Dickinson returns to New Jersey after a Napa detour amid FDA troubles

Becton Dickinson flew from Napa to its Morristown, New Jersey headquarters on May 15, touching down after a 4-hour-36-minute journey in its Falcon 7X, N294X. The trip caps a week that included stops in Las Vegas, Salt Lake City, and El Paso — the site of a manufacturing plant under an FDA warning letter.

The visit to El Paso comes as Becton Dickinson works to resolve a warning letter tied to its ChloraPrep and PurPrep infection prevention products, with the company placing a voluntary ship hold on U.S. sales while completing additional testing, per a May 9 MarketBeat report. The return to Morristown also follows Becton Dickinson’s strong fiscal Q2 earnings release on May 7, where it reported revenue of $4.7 billion — above analyst expectations — and raised its full-year adjusted EPS guidance to $12.52–$12.72, as covered by the Associated Press.

The recent flight pattern — a May 8 jaunt to El Paso, then Salt Lake, Las Vegas, and finally Napa — suggests a multi-city business tour by CEO Tom Polen, likely combining factory oversight, investor meetings, and perhaps a strategic pause in wine country before heading back to the C-suite.